Correction: Influenza a(H1N1)pdm09 and Cystic Fibrosis Lung Disease: a Systematic Meta-Analysis (PLoS ONE (2014) 9, 1 (e78583) DOI: 10.1371/journal.pone.0078583);Influenza a(H1N1)pdm09 and cystic fibrosis lung disease: A systematic meta-analysis

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Renk, Hanna ^a   Regamey, Nicolas ^b   Hartl, Dominik ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIVIRUS AGENT;

ARTHRALGIA; ARTICLE; ASTHMA; CLINICAL FEATURE; COUGHING; CYSTIC FIBROSIS; DISEASE PREDISPOSITION; DISEASE SEVERITY; DYSPNEA; EARLY INTERVENTION; FATIGUE; FEVER; GASTROINTESTINAL SYMPTOM; HEADACHE; HEALTH CARE COST; HEMOPTYSIS; HOSPITALIZATION; HUMAN; INCIDENCE; INFLUENZA A (H1N1); META ANALYSIS; MORBIDITY; MYALGIA; PERSONAL HYGIENE; SEASONAL INFLUENZA; SORE THROAT; SYSTEMATIC REVIEW;

ADOLESCENT; ADULT; CYSTIC FIBROSIS; HOSPITALIZATION; HUMANS; INCIDENCE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LUNG DISEASES; SURVIVAL RATE; YOUNG ADULT;

EID: 84897521284     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093142     Document Type: Erratum

References (59)

1. CDC (2009) Swine influenza A (H1N1) infection in two children-Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep 58: 400-402.
2. Chan M (2009) World now at the start of 2009 influenza pandemic - Statement to the press by WHO Director-General Dr Margaret Chan. WHO Media centre.
3. WHO (2013) Epidemiological and virological situation update of the 2012/2013 influenza season in the WHO European Region. WHO Europe Publications. Available: http://www.euro.who.int/--data/assets/pdf-file/0010/184690/Epi-and- virological-update-of-the-2012-13-influenza-season-in-the-WHO-EURO-EuroFlu-data- week-40,2012-to-week-04,2013.pdf.
4. Canada PHAo Public Health Agency of Canada. Flu Watch - January 30 to 5 Febrary, 2011 (week 05).
5. Inamasu T, Sudo K, Kato S, Deguchi H, Ichikawa M, et al. (2012) Pandemic influenza virus surveillance, Izu-Oshima Island, Japan. Emerg Infect Dis 18: 1882-1885.
6. Lopez L, Bandaranayake D, Huang QS (2011) Influenza surveillance in New Zealand 2010. Wellington: Institute of Environmental Science and Research Ltd.
7. Mytton OT, Rutter PD, Donaldson LJ (2012) Influenza A(H1N1)pdm09 in England, 2009 to 2011: a greater burden of severe illness in the year after the pandemic than in the pandemic year. Euro Surveill 17.
8. WHO (2013) Influenza update No 182. 182: 3-4. Available: http://www.who.int/influenza/surveillance-monitoring/updates/ 2013-04-02-surveillance-update-182.pdf.
9. Munster VJ, de Wit E, van den Brand JM, Herfst S, Schrauwen EJ, et al. (2009) Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 325: 481-483.
10. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, et al. (2009) In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460: 1021-1025.
11. Pecavar B, Nadrah K, Papst L, Cec V, Kotar T, et al. (2011) Clinical characteristics of adult patients with influenza-like illness hospitalized in general ward during Influenza A H1N1 pandemic 2009/2010. Wien Klin Wochenschr 123: 662-667.
12. Lera E, Worner NT, Sancosmed M, Fabregas A, Casquero A, et al. (2011) Clinical and epidemiological characteristics of patients with influenza A (H1N1) 2009 attended to at the emergency room of a children's hospital. Eur J Pediatr 170: 371-378.
13. McKenna JJ, Bramley AM, Skarbinski J, Fry AM, Finelli L, et al. (2013) Asthma in patients hospitalized with pandemic influenza A(H1N1)pdm09 virus infection-United States, 2009. BMC Infect Dis 13: 57.
14. Institute RK (2009) Epidemiologisches Bulletin. October 12, 2009/Nr. 41: 409.
15. Yang L, Wang XL, Chan KP, Cao PH, Lau HY, et al. (2012) Hospitalisation associated with the 2009 H1N1 pandemic and seasonal influenza in Hong Kong, 2005 to 2010. Euro Surveill 17.
16. Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, et al. (2010) Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 362: 1708-1719.
17. Sachedina N, Donaldson LJ (2010) Paediatric mortality related to pandemic influenza A H1N1 infection in England: an observational population-based study. Lancet 376: 1846-1852.
18. Myles PR, Semple MG, Lim WS, Openshaw PJ, Gadd EM, et al. (2012) Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK. Thorax 67: 709-717.
19. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, et al. (2009) Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 361: 1935-1944.
20. CDC (2009) Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. MMWR Morb Mortal Wkly Rep 58: 1071-1074.
21. Muscedere J, Ofner M, Kumar A, Long J, Lamontagne F, et al. (2013) The Occurrence and Impact of Bacterial Organisms Complicating Critical Care Illness Associated with Influenza A(H1N1) infection. Chest.
22. Randolph AG, Vaughn F, Sullivan R, Rubinson L, Thompson BT, et al. (2011) Critically ill children during the 2009-2010 influenza pandemic in the United States. Pediatrics 128: e1450-1458.
23. Hadler JL, Konty K, McVeigh KH, Fine A, Eisenhower D, et al. (2010) Case fatality rates based on population estimates of influenza-like illness due to novel H1N1 influenza: New York City, May-June 2009. PLoS One 5: e11677.
24. Nishiura H (2010) The virulence of pandemic influenza A (H1N1) 2009: an epidemiological perspective on the case-fatality ratio. Expert Rev Respir Med 4: 329-338.
25. Presanis AM, De Angelis D, Hagy A, Reed C, Riley S, et al. (2009) The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med 6: e1000207.
26. WHO (2013) Genes and human disease: Monogenic diseases - Cystic Fibrosis. Genomic resource centre. Available: http://www.who.int/genomics/public/ geneticdiseases/en/index2.html# CF.
27. Mehta G, Macek M Jr, Mehta A (2010) Cystic fibrosis across Europe: EuroCareCF analysis of demographic data from 35 countries. J Cyst Fibros 9 Suppl 2: S5-S21.
28. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, et al. (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245: 1066-1073. (Pubitemid 19231814)
29. Rosenstein BJ, Zeitlin PL (1998) Cystic fibrosis. Lancet 351: 277-282. (Pubitemid 28043961)
30. Rowe SM, Miller S, Sorscher EJ (2005) Cystic Fibrosis. New England Journal of Medicine 352: 1992-2001. (Pubitemid 40638370)
31. Burns JL, Emerson J, Kuypers J, Campbell AP, Gibson RL, et al. (2012) Respiratory viruses in children with cystic fibrosis: viral detection and clinical findings. Influenza Other Respi Viruses 6: 218-223.
32. Hoek RA, Paats MS, Pas SD, Bakker M, Hoogsteden HC, et al. (2013) Incidence of viral respiratory pathogens causing exacerbations in adult cystic fibrosis patients. Scand J Infect Dis 45: 65-69.
33. Wat D (2003) Impact of respiratory viral infections on cystic fibrosis. Postgrad Med J 79: 201-203.
34. van Ewijk BE, van der Zalm MM, Wolfs TF, van der Ent CK (2005) Viral respiratory infections in cystic fibrosis. J Cyst Fibros 4 Suppl 2: 31-36. (Pubitemid 41131326)
35. Stelzer-Braid S, Johal H, Skilbeck K, Steller A, Alsubie H, et al. (2012) Detection of viral and bacterial respiratory pathogens in patients with cystic fibrosis. J Virol Methods 186: 109-112.
36. Wang EE, Prober CG, Manson B, Corey M, Levison H (1984) Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. N Engl J Med 311: 1653-1658. (Pubitemid 15183995)
37. van Ewijk BE, van der Zalm MM, Wolfs TF, Fleer A, Kimpen JL, et al. (2008) Prevalence and impact of respiratory viral infections in young children with cystic fibrosis: prospective cohort study. Pediatrics 122: 1171-1176.
38. Wat D, Doull I (2003) Respiratory virus infections in cystic fibrosis. Paediatric Respiratory Reviews 4: 172-177. (Pubitemid 36987173)
39. Viviani L, Assael BM, Kerem E (2011) Impact of the A (H1N1) pandemic influenza (season 2009-2010) on patients with cystic fibrosis. J Cyst Fibros 10: 370-376.
40. Nash EF, Whitmill R, Barker B, Rashid R, Whitehouse JL, et al. (2011) Clinical outcomes of pandemic (H1N1) 2009 influenza (swine flu) in adults with cystic fibrosis. Thorax 66: 259.
41. Colombo C, Battezzati PM, Lucidi V, Magazzu G, Motta V, et al. (2011) Influenza A/H1N1 in patients with cystic fibrosis in Italy: a multicentre cohort study. Thorax 66: 260-261.
42. France MW, Tai S, Masel PJ, Moore VL, McMahon TL, et al. (2010) The month of July: an early experience with pandemic influenza A (H1N1) in adults with cystic fibrosis. BMC Pulm Med 10: 8.
43. Taylor-Robinson D, Whitehead M, Diderichsen F, Olesen HV, Pressler T, et al. (2012) Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study. Thorax 67: 860-866.
44. Ling LM, Chow AL, Lye DC, Tan AS, Krishnan P, et al. (2010) Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection. Clin Infect Dis 50: 963-969.
45. Morens DM, Taubenberger JK, Fauci AS (2008) Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 198: 962-970.
46. Rice TW, Rubinson L, Uyeki TM, Vaughn FL, John BB, et al. (2012) Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit Care Med 40: 1487-1498.
47. Doring G, Flume P, Heijerman H, Elborn JS (2012) Treatment of lung infection in patients with cystic fibrosis: current and future strategies. J Cyst Fibros 11: 461-479.
48. Nguyen-Van-Tam JS, Openshaw PJ, Hashim A, Gadd EM, Lim WS, et al. (2010) Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009). Thorax 65: 645-651.
49. Ramsey BW, Gore EJ, Smith AL, Cooney MK, Redding GJ, et al. (1989) The effect of respiratory viral infections on patients with cystic fibrosis. Am J Dis Child 143: 662-668. (Pubitemid 19145399)
50. Kieninger E, Singer F, Tapparel C, Alves MP, Latzin P, et al. (2012) High rhinovirus burden in lower airways of children with cystic fibrosis. Chest.
51. Zheng S, De BP, Choudhary S, Comhair SA, Goggans T, et al. (2003) Impaired innate host defense causes susceptibility to respiratory virus infections in cystic fibrosis. Immunity 18: 619-630. (Pubitemid 36588579)
52. Xu W, Zheng S, Goggans TM, Kiser P, Quinones-Mateu ME, et al. (2006) Cystic fibrosis and normal human airway epithelial cell response to influenza a viral infection. J Interferon Cytokine Res 26: 609-627. (Pubitemid 44689650)
53. Sutanto EN, Kicic A, Foo CJ, Stevens PT, Mullane D, et al. (2011) Innate inflammatory responses of pediatric cystic fibrosis airway epithelial cells: effects of nonviral and viral stimulation. Am J Respir Cell Mol Biol 44: 761-767.
54. Kieninger E, Vareille M, Kopf BS, Blank F, Alves MP, et al. (2012) Lack of an exaggerated inflammatory response on virus infection in cystic fibrosis. Eur Respir J 39: 297-304.
55. Van Ewijk BE, Wolfs TF, Aerts PC, Van Kessel KP, Fleer A, et al. (2007) RSV mediates Pseudomonas aeruginosa binding to cystic fibrosis and normal epithelial cells. Pediatr Res 61: 398-403. (Pubitemid 46569290)
56. Chattoraj SS, Ganesan S, Jones AM, Helm JM, Comstock AT, et al. (2011) Rhinovirus infection liberates planktonic bacteria from biofilm and increases chemokine responses in cystic fibrosis airway epithelial cells. Thorax 66: 333-339.
57. Patria MF, Longhi B, Esposito S (2013) Influenza vaccination in children with cystic fibrosis. Expert Rev Vaccines 12: 415-420.
58. Hollmeyer H, Hayden F, Mounts A, Buchholz U (2012) Review: interventions to increase influenza vaccination among healthcare workers in hospitals. Influenza Other Respi Viruses.
59. Bohmer MM, Walter D, Falkenhorst G, Muters S, Krause G, et al. (2012) Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany. BMC Public Health 12: 938.